Evaluation of antimicrobial combinations against colistin-resistant carbapenemase (KPC)-producing Klebsiella pneumoniae

References

• TzouvelekisLS, MarkogiannakisA, PsichogiouM, TassiosPT, DaikosGL.Carbapenemases in Klebsiella pneumoniae and other enterobacteriaceae: an evolving crisis of global dimensions.Clin Microbiol Rev.2012;25(4):682–707.
   PubMed Web of Science ®Google Scholar
• KitchelB, RasheedJK, PatelJB, SrinivasanA, Navon-VeneziaS, CarmeliY, et al.Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.Antimicrob Agents Chemother.2009;53(8):3365–70.
   PubMed Web of Science ®Google Scholar
• Navon-VeneziaS, LeavittA, SchwaberMJ, RasheedJK, SrinivasanA, PatelJB, et al.First report on an hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.Antimicrob Agents Chemother.2009;53(2):818–20.
   PubMed Web of Science ®Google Scholar
• PournarasS, ProtonotariouE, VoulgariE, KristoI, DimitrouliaE, VittiD, et al.Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.J Antimicrob Chemother.2009;64(2):348–52.
   PubMed Web of Science ®Google Scholar
• RiceLB, CariasLL, HuttonRA, RudinSD, EndimianiA, BonomoRA.The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae.Antimicrob Agents Chemother.2008;52(9):3427–9.
   PubMed Web of Science ®Google Scholar
• CarmeliY, AkovaM, CornagliaG, DaikosGL, GarauJ, HarbarthS, et al.Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.Clin Microbiol Infect.2010;16(2):102–11.
   PubMed Web of Science ®Google Scholar
• LeeGC, BurgessDS.Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.Ann Clin Microbiol Antimicrob.2012;11:32.
   PubMed Web of Science ®Google Scholar
• QureshiZA, PatersonDL, PotoskiBA, KilaykoMC, SandovskyG, SordilloE, et al.Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.Antimicrob Agents Chemother.2012;56(4):2108–13.
   PubMed Web of Science ®Google Scholar
• DaikosGL, TsaousiS, TzouvelekisLS, AnyfantisI, PsichogiouM, ArgyropoulouA, et al.Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.Antimicrob Agents Chemother.2014;58(4):2322–8.
   PubMed Web of Science ®Google Scholar
• NaasT, CuzonG, VillegasMV, LartiqueMF, QuinnJP, NordmannP.Genetic structures at the origin of acquisition of the beta-lactamase blaKPC gene.Antimicrob Agents Chemother.2008;52(4):1257–63.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard-ninth edn. Wayne, PA: Clinical and Laboratory Standards Institute; 2012. p. M07-A9.
   Google Scholar
• European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation for MICs and zone diameters: version 3.1, valid from 2013-02-11. Basel, Switzerland: EUCAST. 2013.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 23rd informational supplement edn. Wayne, PA: Clinical and Laboratory Standards Institute; 2013. p. M100-S23.
   Google Scholar
• LorienV, EliopoulosGM, MoelleringRCJr.Antimicrobial combinations. In: Lorien V, editor. Antibiotics in laboratory medicine, 4th edn. Baltimore: The Williams & Wilkins Co. 1996 p. 330–96.
   Google Scholar
• OddsFC.Synergy, antagonism, and what the chequerboard puts between them.J Antimicrob Chemother.2003;52:1.
   PubMed Web of Science ®Google Scholar
• NordmannP, CuzonG, NaasT.The real threat of Klebsiella pneumoniae carbapenemase producing bacteria.Lancet Infect Dis.2009;9(4):228–36.
   PubMed Web of Science ®Google Scholar
• EllingtonMJ, LivermoreDM, PittTL, HallLM, WoodfordN.Mutators among CTX-M β-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.J Antimicrob Chemother.2006;58(4):848–52.
   PubMed Web of Science ®Google Scholar
• MeletisG, TzampazE, SianouE, TzavarasI, SofianouD.Colistin heteroresistance in carbapenemase producing Klebsiella pneumoniae.J Antimicrob Chemother.2011;66(4):946–7.
   PubMed Web of Science ®Google Scholar
• FalagasME, LouridaP, PoulikakosP, RafailidisPI, TansarliGS.Antibiotic treatment of infections due to carbapenem-resistant enterobacteriaceae: systematic evaluation of the available evidence.Antimicrob Agents Chemother.2014;58(2):654–63.
   PubMed Web of Science ®Google Scholar
• TasciniC, TagliaferriE, GianiT, LeonildiA, FlamminiS, CasiniB, et al.Synergistic activity of colistin plus rifampicin against colistin-resistant KPC-producing Klebsiella pneumoniae.Antimicrob Agents Chemother.2013;57(8):3990–3.
   PubMed Web of Science ®Google Scholar
• GaibaniP, LombardoD, LewisRE, MercuriM, BonoraS, LandiniMP, et al.In vitro activities and post-antibiotic effect of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.J Antimicrob Chemother.2014;69(7):1856–65.
   PubMed Web of Science ®Google Scholar
• BratuS, TolaneyP, KarumudiU, QualeJ, MootyM, NichaniS, et al.Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.J Antimicrob Chemother.2005;56(1):128–32.
   PubMed Web of Science ®Google Scholar
• ElemamA, RahimianJ, DoymazM.In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.J Clin Microbiol.2010;48(10):3558–62.
   PubMed Web of Science ®Google Scholar
• KádárB, KocsisB, TóthÁ, DamjanovaI, SzászM, KristófK, et al.Synergistic antibiotic combinations for colistin resistant Klebsiella pneumoniae.Acta Microbiol Immunol Hung.2013;60(2):201–9.
   PubMed Web of Science ®Google Scholar
• JerniganMG, PressEG, NguyenMH, ClancyCJ, ShieldsRK.The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae.Antimicrob Agents Chemother.2012;56(6):3395–8.
   PubMed Web of Science ®Google Scholar
• LeeGC, BurgessDS.Polymyxins and doripenem combination against KPC-producing Klebsiella pneumoniae.J Clin Med Res.2013;5(2):97–100.
   PubMedGoogle Scholar
• PournarasS, VrioniG, NeouE, DendrinosJ, DimitrouliaE, PoulouA, et al.Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing enterobacteriaceae strains by time-kill assay.Int J Antimicrob Agents.2011;37(3):244–7.
   PubMed Web of Science ®Google Scholar
• YoonJ, UrbanC, TerzianC, MarianoN, RahalJ.In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampicin against multidrug-resistant Acinetobacter baumannii.Antimicrob Agents Chemother.2004;48(3):753–7.
   PubMed Web of Science ®Google Scholar
• PankeyGA, AshcraftDS, DornellesA.Comparison of 3 Etest methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella pneumoniae.Diagn Microbiol Infect Dis.2013;77(3):220–6.
   PubMed Web of Science ®Google Scholar